Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.04 per share
-
Shares outstanding
-
106,324,269
-
Total 13F shares
-
9,002,972
-
Share change
-
+376,963
-
Total reported value
-
$46,815,000
-
Price per share
-
$5.20
-
Number of holders
-
17
-
Value change
-
+$1,972,554
-
Number of buys
-
8
-
Number of sells
-
4
Institutional Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value EUR0.04 per share (PRQR) as of Q2 2017
As of 30 Jun 2017,
ProQR Therapeutics N.V. - Ordinary Shares, nominal value EUR0.04 per share (PRQR) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,002,972 shares.
The largest 10 holders included
JENNISON ASSOCIATES LLC, ORBIMED ADVISORS LLC, Redmile Group, LLC, Clearbridge Investments, LLC, Artal Group S.A., JANUS HENDERSON GROUP PLC, SPHERA FUNDS MANAGEMENT LTD., FRANKLIN RESOURCES INC, FMR LLC, and ALTRINSIC GLOBAL ADVISORS LLC.
This page lists
17
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.